1. Evaluation of effectiveness, safety and cost-benefit of the 23– valent pneumococcal capsular polysaccharide vaccine for HIV-Infected patients. Issue 1 (3rd January 2022) Authors: Zou, Xiaobai; He, Jianmei; Zheng, Jun; Liang, Mengran; Gao, Jinjin; Huang, Jianwen; Jiang, Yang; Jiang, Yonglin; Chen, Xi Journal: Vaccine Issue: Volume 40:Issue 1(2022) Page Start: 37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗